|
HY-15096-5mg
|
MedChemexpress LLC
|
MKT-077 [CAS 147366-41-4]
|
|
Cancer-programmed cell death
|
|
|
HY-15096-50mg
|
MedChemexpress LLC
|
MKT-077 [CAS 147366-41-4]
|
|
Cancer-programmed cell death
|
|
|
HY-15096-1mL
|
MedChemexpress LLC
|
MKT-077 [CAS 147366-41-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-R03218-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p mimic
|
|
Cancer-programmed cell death
|
|
|
HY-R03218-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-3p mimic
|
|
Cancer-programmed cell death
|
|
|
HY-R03219-20nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p mimic
|
|
Cancer-programmed cell death
|
|
|
HY-R03219-5nmol
|
MedChemexpress LLC
|
mMu -miR-488-5p mimic
|
|
Cancer-programmed cell death
|
|
|
HY-D1261-10mg
|
MedChemexpress LLC
|
Naph-EA-mal [CAS 210292-65-2]
|
|
|
|
|
HY-D1261-5mg
|
MedChemexpress LLC
|
Naph-EA-mal [CAS 210292-65-2]
|
|
|
|
|
HY-D1261-1mL
|
MedChemexpress LLC
|
Naph-EA-mal [CAS 210292-65-2] (10mM in DMSO)
|
|
|
|
|
HY-P71087-10ug
|
MedChemexpress LLC
|
P4HB, Human (HEK293, His)
|
|
|
|
|
HY-P71087-50ug
|
MedChemexpress LLC
|
P4HB, Human (HEK293, His)
|
|
|
|
|
HY-100472-10mg
|
MedChemexpress LLC
|
ZYZ-488 [CAS 1470302-79-4]
|
|
Cancer-programmed cell death
|
|
|
HY-100472-100mg
|
MedChemexpress LLC
|
ZYZ-488 [CAS 1470302-79-4]
|
|
Cancer-programmed cell death
|
|
|
HY-100472-5mg
|
MedChemexpress LLC
|
ZYZ-488 [CAS 1470302-79-4]
|
|
Cancer-programmed cell death
|
|
|
HY-100472-50mg
|
MedChemexpress LLC
|
ZYZ-488 [CAS 1470302-79-4]
|
|
Cancer-programmed cell death
|
|
|
HY-100472-1mL
|
MedChemexpress LLC
|
ZYZ-488 [CAS 1470302-79-4] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
